SILENCE THERAP. SP.ADR/1 (XRP2) — Long-term Investment Intensity
SILENCE THERAP. SP.ADR/1 (XRP2) has a Long-term Investment Intensity of 0.2% as of September 2024. Long-term investments of €380.05K represent 0.2% of total assets of €226.67 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of SILENCE THERAP. SP.ADR/1 to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SILENCE THERAP. SP.ADR/1 Long-term Investment Intensity (2021–2023)
This chart shows how SILENCE THERAP. SP.ADR/1's Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2023. As of September 2024, the intensity stands at 0.2%, reflecting long-term investments of €380.05K against total assets of €226.67 Million EUR. Explore SILENCE THERAP. SP.ADR/1 (XRP2) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for SILENCE THERAP. SP.ADR/1 (2021–2023)
The table below presents the year-by-year Long-term Investment Intensity for SILENCE THERAP. SP.ADR/1 from 2021 to 2023, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see XRP2 market cap overview.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.3% | €361.79K | €119.45 Million | ▲ +0.0 pp |
| 2022 | 0.3% | €343.70K | €130.10 Million | ▼ 0.0 pp |
| 2021 | 0.3% | €406.24K | €129.83 Million | — |